Form 4 for RCKT ROCKET PHARMACEUTICALS, INC.
Accepted 2022-10-11 00:00:00 ET · period of report 2022-10-06 · accession 0000902664-22-004508 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-10-11 | 2022-10-06 | RCKT | RTW INVESTMENTS, LP | Dir, 10%, See Remarks | P - Purchase | $14.75 | +1.36M | 17.63M | +8% | +$20.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 par value ("Common Stock") | 2022-10-06 | P | A | 1,355,932 | $14.75 | 17,628,567 | I See footnote | — | — | (F1) This Form 4 is being filed by each of (i) RTW Investments, LP (the "Adviser") with respect to the shares of Common Stock held by certain investment funds managed by the Adviser (the "RTW Funds") and (ii) Roderick Wong, M.D. ("Dr. Wong"), who serves as the Managing Partner and Chief Investment Officer of the Adviser and who is a director of the Issuer and Chairman of the Issuer's Board of Directors. |